计算机辅助主动脉阻断导管在非创伤性心脏骤停中的可行性
该单臂研究在德国两家三级医院纳入10例非创伤性心脏骤停患者(含院内外),评估计算机辅助自动主动脉阻断导管(NEURESCUE® Catheter & NEURESCUE® Assistant)作为高级心血管生命支持辅助手段的可行性与安全性。主要终点为首次血管穿刺后10分钟内球囊成功充盈,8/9例达标,平均时间5.4分钟(±2.5分钟)。球囊置入成功率100%(10/10)。主动脉阻断2分钟后80%患者收缩压、舒张压和平均动脉压分别较基线升高24.6 mmHg、7.3 mmHg和13.0 mmHg。主要复合安全终点发生1例(需肾脏替代治疗的肾衰竭)。作者结论认为该导管可在心肺复苏过程中安全置入且成功率高。
要点
- 单臂研究纳入10例非创伤性心脏骤停患者,球囊置入成功率100%(10/10)。
- 主要终点(首次血管穿刺后10分钟内球囊成功充盈)8/9例达标,平均时间5.4分钟(±2.5分钟)。
- 主动脉阻断2分钟后,80%患者收缩压、舒张压、平均动脉压分别较基线升高24.6 mmHg、7.3 mmHg、13.0 mmHg。
- 主要复合安全终点发生1例,为需肾脏替代治疗的肾衰竭。
- 作者结论认为该计算机辅助自动主动脉阻断导管可在持续心肺复苏中安全置入且成功率高。
适用人群与场景
- 非创伤性心脏骤停患者,包括院内心脏骤停和院外心脏骤停。
- 研究在德国两家三级医院(海德堡大学医院和柏林夏里特德国心脏中心)进行。
研究设计与关键结果
- 研究类型:单臂研究,样本量10例,在德国两家三级医院进行。
- 干预:计算机辅助自动主动脉阻断导管(NEURESCUE® Catheter & NEURESCUE® Assistant)作为高级心血管生命支持的辅助手段。
- 主要终点:首次血管穿刺后10分钟内球囊成功充盈,8/9例达标,平均时间5.4分钟(±2.5分钟)。
- 球囊置入成功率:10/10(100%)。
- 血流动力学:主动脉阻断2分钟后,80%患者收缩压、舒张压、平均动脉压分别较基线升高24.6 mmHg(基线均值44.1 mmHg)、7.3 mmHg(基线均值23.4 mmHg)、13.0 mmHg(基线均值30.3 mmHg)。
- 主要复合安全终点:1例发生需肾脏替代治疗的肾衰竭。
证据类型、等级与局限
- 证据类型:单臂研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,计算机辅助自动主动脉阻断导管可在非创伤性心脏骤停患者持续心肺复苏中安全置入且成功率高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The persistently high mortality rate following cardiac arrest over the past decades underscores the urgent need for advancements in resuscitation strategies. Animal studies have shown increased coronary and cerebral perfusion during cardiopulmonary resuscitation following endovascular balloon occlusion of the aorta.
METHODS: This single-arm study investigated the feasibility and safety of a novel computer-aided automated aortic occlusion catheter (NEURESCUE® Catheter & NEURESCUE® Assistant) as an adjunct to advanced cardiac life support in patients with non-traumatic cardiac arrest. Both in-hospital and out-of-hospital cardiac arrest cases were included in two German tertiary care hospitals (University Hospital of Heidelberg and Deutsches Herzzentrum der Charité (DHZC) Berlin). The primary endpoint was defined as successful balloon inflation within 10 min from the first vessel puncture. The primary safety endpoint was a composite of adverse outcomes, including blood vessel damage resulting from the device requiring surgical or endovascular intervention, arterial thromboembolism necessitating surgical or endovascular intervention, lower extremity amputation, renal failure requiring non-temporary renal replacement therapy, and lower extremity paralysis.
RESULTS: In total, ten subjects were enrolled in the trial. The balloon was successfully implanted in ten out of ten (100 %) subjects. The primary endpoint was achieved in eight out of nine with a mean time of 5.4 min (±2.5 min) from first vessel puncture to total aortic balloon occlusion. Systolic, diastolic, and mean arterial blood pressure during resuscitation were increased in 80 % of the patients after two minutes of aortic occlusion by 24.6 mmHg (baseline mean: 44.1 mmHg), 7.3 mmHg (baseline mean: 23.4 mmHg) and 13.0 mmHg (baseline mean: 30.3 mmHg), respectively. The primary composite safety endpoint was evident in one patient, who experienced renal failure requiring renal replacement therapy.
CONCLUSIONS: A computer-aided automated aortic occlusion catheter can be safely implanted with a high success rate with regards to procedure time during ongoing cardiopulmonary resuscitation in patients suffering from cardiac arrest of non-traumatic origin.
参考来源
- Rusnak J, Thevathasan T, Skurk C, et al. Feasibility of computer-aided aortic occlusion catheter in non-traumatic cardiac arrest. Resuscitation. 2025. PMID: 41237845. doi:10.1016/j.resuscitation.2025.110879
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。